Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model

MLA

Michael R. Green, et al. Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b67bfd2fea1cc7b00e81a98744a5a7ed&authtype=sso&custid=ns315887.

APA

Michael R. Green, Beth Chasen, Annette Künkele, Charlotte Kloft, Wilhelm Huisinga, Paolo Strati, Nahum Puebla-Osorio, Anna Mueller-Schoell, Cassian Yee, Robin Michelet, & Sattva S. Neelapu. (2021). Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model.

Chicago

Michael R. Green, Beth Chasen, Annette Künkele, Charlotte Kloft, Wilhelm Huisinga, Paolo Strati, Nahum Puebla-Osorio, et al. 2021. “Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b67bfd2fea1cc7b00e81a98744a5a7ed&authtype=sso&custid=ns315887.